Clinical Trial Update: Evaluation of the Therapeutic Effects of Curcumin on Changes in Lipid, Metabolic, and Hormonal Profiles, Liver Enzyme Activity, and Ultrasonography Morphology of the Liver in Women With Polycystic Ovary Syndrome and Nonalcoholic Fatty Liver Disease: A Double-blind, Placebo-controlled Clinical Trial [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial evaluating curcumin's effects on lipid, metabolic and hormonal profiles and liver morphology in women with PCOS and NAFLD; Phase 2/Phase 3 comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Polycystic Ovary Syndrome

Drugs mentioned

• Curcumin (curcumin)

Snippet

Sponsor: Fateme Moshirenia | Conditions: Polycystic Ovary Syndrome (PCOS) With Concurrent Nonalcoholic Fatty Liver Disease (NAFLD) | Phase 2, Phase 3 | Status: COMPLETED